Singapore, June 25 -- China-based ATLATL Innovation Center, a global innovation platform for life science research and development, and Korea's Samsung Bioepis have announced the launch of the Samsung Bioepis Innovation Prize C-Lab Outside (Innovation Prize), an open innovation initiative designed to identify and support promising early-stage biotech companies across the Asia-Pacific region.

The programme seeks innovative startups and emerging biotech companies working in the following therapeutic areas:

Areas of particular interest include:

Selected companies will gain access to ATLATL's world-class laboratory infrastructure, entrepreneurial resources, and industry mentorship. In addition, awardees will have the opportunity to engage ...